Authors:
Stroup, GB
Hoffman, SJ
Vasko-Moser, JA
Lechowska, BA
Jenkins, EL
Dare, LC
Gowen, M
Citation: Gb. Stroup et al., Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: A short-term model for evaluation of antiresorptive therapy, BONE, 28(5), 2001, pp. 532-537
Authors:
Lark, MW
Stroup, GB
Dodds, RA
Kapadia, R
Hoffman, SJ
Hwang, SM
James, IE
Lechowska, B
Liang, XG
Rieman, DJ
Salyers, KL
Ward, K
Smith, BR
Miller, WH
Huffman, WF
Gowen, M
Citation: Mw. Lark et al., Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat, J BONE MIN, 16(2), 2001, pp. 319-327
Authors:
Stroup, GB
Lark, MW
Veber, DF
Bhattacharyya, A
Blake, S
Dare, LC
Erhard, KF
Hoffman, SJ
James, IE
Marquis, RW
Ru, Y
Vasko-Moser, JA
Smith, BR
Tomaszek, T
Gowen, M
Citation: Gb. Stroup et al., Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate, J BONE MIN, 16(10), 2001, pp. 1739-1746
Citation: Sj. Hoffman, Progressive public health administration in the Jim Crow South: A case study of Richmond, Virginia, 1907-1920, J SOC HIST, 35(1), 2001, pp. 175
Citation: Sj. Hoffman, AlabamaNorth: African-American migrants, community and working-class activism in Cleveland, 1915-45., J SOC HIST, 35(1), 2001, pp. 229-233
Authors:
Badger, AM
Blake, S
Kapadia, R
Sarkar, S
Levin, J
Swift, BA
Hoffman, SJ
Stroup, GB
Miller, WH
Gowen, M
Lark, MW
Citation: Am. Badger et al., Disease-modifying activity of SB 273005, an orally active, nonpeptide alpha(v)beta(3) (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis, ARTH RHEUM, 44(1), 2001, pp. 128-137
Authors:
Grella, MP
Danso-Danquah, R
Safo, MK
Joshi, GS
Kister, J
Marden, M
Hoffman, SJ
Abraham, DJ
Citation: Mp. Grella et al., Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin, J MED CHEM, 43(25), 2000, pp. 4726-4737
Authors:
Badger, AM
Griswold, DE
Kapadia, R
Blake, S
Swift, BA
Hoffman, SJ
Stroup, GB
Webb, E
Rieman, DJ
Gowen, M
Boehm, JC
Adams, JL
Lee, JC
Citation: Am. Badger et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis, ARTH RHEUM, 43(1), 2000, pp. 175-183
Authors:
Miller, WH
Bondinell, WE
Cousins, RD
Erhard, KF
Jakas, DR
Keenan, RM
Ku, TW
Newlander, KA
Ross, ST
Haltiwanger, RC
Bradbeer, J
Drake, FH
Gowen, M
Hoffman, SJ
Hwang, SM
James, IE
Lark, MW
Lechowska, B
Rieman, DJ
Stroup, GB
Vasko-Moser, JA
Zembryki, DL
Azzarano, LM
Adams, PC
Salyers, KL
Smith, BR
Ward, KW
Johanson, KO
Huffman, WF
Citation: Wh. Miller et al., Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model, BIOORG MED, 9(13), 1999, pp. 1807-1812
Authors:
Badger, AM
Blake, SM
Dodds, RA
Griswold, DE
Swift, BA
Rieman, DJ
Stroup, GB
Hoffman, SJ
Gowen, M
Citation: Am. Badger et al., Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis, J PHARM EXP, 291(3), 1999, pp. 1380-1386